Regeneron gains approval of every 20 week dosing for Eylea HD.
Share this article
Corporate
Score 55
Bullish
Regeneron gains approval of every 20 week dosing for Eylea HD
Apr 02, 2026 17:27 UTC
REGN
Short term
Related Articles
Score 65
Saudi Fund in Talks for $5 Billion Stake in SpaceX IPO
Apr 02, 18:24
Score 25
Union Pacific EVP Gehringer sells $469k in stock
Apr 02, 18:22
Score 25
Form 6K TNL Mediagene For: 2 April
Apr 02, 18:20
Score 65
U.S. Regulator Files Lawsuit Against Three States Over Prediction Market Regulations
Apr 02, 18:19
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.